Participants should call (877) 377-7550 (United States/Canada) or (678) 224-7859 (International) and request the SIGA call or provide confirmation code 96658993. A live broadcast of the call will be available on the Company's website at www.SIGA.com under the 'Events & Presentations' tab in the Investor Relations section.

A replay of the call will be available approximately two hours after the call and will be accessible until 11:59 P.M. ET on November 20, 2013. To listen to the replay, dial (855) 859-2056 (Domestic) or (404) 537-3406 (International) and enter the code 96658993. The webcast of the event will also be archived on the Company's website for two weeks under the 'Events & Presentations' tab in the Investor Relations section.

About SIGA Technologies, Inc.

In the United States and around the globe, populations face a serious but unmet need for new drugs to protect against potentially catastrophic emerging viral pathogens and biological weapons of mass destruction. We are a pharmaceutical company specializing in discovering and developing pharmaceutical solutions for some of the most lethal pathogens -- smallpox, Ebola, dengue, Lassa fever and other dangerous viruses. Our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority threats. Our mission is to disarm dreaded viral diseases and create robust, modern biodefense countermeasures